Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

sulfonyl-pyridazinone inhibitor

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND The pyridazinone nucleus has been incorporated into a wide variety of therapeutically interesting molecules to… Expand
2018
2018
Through cell-based screening models, we have identified a new compound IMB5043, a thiophenylated pyridazinone, which exerted… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2018
2018
ISSN: 2410-9649 Asif et al / Chemistry International 5(3) (2019) 206-231 iscientic.org. 
2017
2017
A Lewis base-catalyzed [3 + 2] cycloaddition reaction of nitrones with electron-deficient alkenes has been achieved under mild… Expand
  • table 1
  • table 2
Review
2017
Review
2017
In a recent publication1 Qin and co-workers report the biological evaluation of compound 17b2, also referred as (±)−5a3, a chiral… Expand
  • table 1
Review
2014
Review
2014
In this review, we report a survey on the synthesis and application of arylazoazines and arylazoazoles as versatile disperse dyes… Expand
  • table 1
  • figure 2
  • figure 3
  • figure 4
  • table 2
2013
2013
La presente invention concerne un compose pyridazinone de formule (I) et son utilisation comme activateur de resistance induite… Expand
Review
2002
Review
2002
In the last years, alpha(1) adrenoceptors (alpha(1)-AR) have been the subject of intense research, in part because receptor… Expand
Highly Cited
2001
Highly Cited
2001
A series of new pyridazin-3(2H)-one derivatives (3 and 4) were evaluated for their in vitro affinity toward both alpha(1)- and… Expand